AAAAAA

   
Results: 1-19 |
Results: 19
Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2)
Authors: van de Vijver, MJ
Citation: Mj. Van De Vijver, Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2), EUR J CANC, 37, 2001, pp. S11-S17
Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
Authors: Bijker, N Peterse, JL Duchateau, L Julien, JP Fentiman, IS Duval, C Di Palma, S Simony-Lafontaine, J de Mascarel, I van de Vijver, MJ
Citation: N. Bijker et al., Risk factors for recurrence and metastasis after breast-conserving therapyfor ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853, J CL ONCOL, 19(8), 2001, pp. 2263-2271
Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increasedrisk on distant metastasis
Authors: Elkhuizen, PHM Hermans, J Leer, JWH van de Vijver, MJ
Citation: Phm. Elkhuizen et al., Isolated late local recurrences with high mitotic count and early local recurrences following breast-conserving therapy are associated with increasedrisk on distant metastasis, INT J RAD O, 50(2), 2001, pp. 387-396
Determining MDR1/P-glycoprotein expression in breast cancer
Authors: Faneyte, IF Kristel, PMP van de Vijver, MJ
Citation: If. Faneyte et al., Determining MDR1/P-glycoprotein expression in breast cancer, INT J CANC, 93(1), 2001, pp. 114-122
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues
Authors: Maliepaard, M Scheffer, GL Faneyte, IF van Gastelen, MA Pijnenborg, ACLM Schinkel, AH van de Vijver, MJ Scheper, RJ Schellens, JHM
Citation: M. Maliepaard et al., Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues, CANCER RES, 61(8), 2001, pp. 3458-3464
Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients
Authors: de Bock, GH Tollenaar, RAEM Papelard, H Cornelisse, CJ Devilee, P van de Vijver, MJ
Citation: Gh. De Bock et al., Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients, BR J CANC, 85(9), 2001, pp. 1347-1350
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ
Authors: Bijker, N Peterse, JL Duchateau, L Robanus-Maandag, EC Bosch, CAJ Duval, C Pilotti, S van de Vijver, MJ
Citation: N. Bijker et al., Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinomain situ, BR J CANC, 84(4), 2001, pp. 539-544
The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2
Authors: Lakhani, SR Gusterson, BA Jacquemier, J Sloane, JP Anderson, TJ van de Vijver, MJ Venter, D Freeman, A Antoniou, A McGuffog, L Smyth, E Steel, CM Haites, N Scott, RJ Goldgar, D Neuhausen, S Daly, PA Ormiston, W McManus, R Scherneck, S Ponder, BAJ Futreal, PA Peto, J Stoppa-Lyonnet, D Bignon, YJ Struewing, JP Bishop, DT Klijn, JGM Devilee, P Cornelisse, CJ Lasset, C Lenoir, G Barkardottir, RB Egilsson, V Hamann, U Chang-Claude, J Sobol, H Weber, B Easton, DF Stratton, MR
Citation: Sr. Lakhani et al., The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2, CLIN CANC R, 6(3), 2000, pp. 782-789
Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections
Authors: van den Broek, LJCM van de Vijver, MJ
Citation: Ljcm. Van Den Broek et Mj. Van De Vijver, Assessment of problems in diagnostic and research immunohistochemistry associated with epitope instability in stored paraffin sections, APPL IMMUNO, 8(4), 2000, pp. 316-321
Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers
Authors: Jacobs, JJL Keblusek, P Robanus-Maandag, E Kristel, P Lingbeek, M Nederlof, PM van Welsem, T van de Vijver, MJ Koh, EY Daley, GQ van Lohuizen, M
Citation: Jjl. Jacobs et al., Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers, NAT GENET, 26(3), 2000, pp. 291-299
High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study
Authors: Elkhuizen, PHM van Slooten, HJ Clahsen, PC Hermans, J van de Velde, CJH van den Broek, LCJM van de Vijver, MJ
Citation: Phm. Elkhuizen et al., High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study, J CL ONCOL, 18(5), 2000, pp. 1075-1083
Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix. A report of two cases
Authors: Kersemaekers, AMF van de Vijver, MJ Fleuren, GJ
Citation: Amf. Kersemaekers et al., Comparison of the genetic alterations in two epithelial collision tumors of the uterine cervix. A report of two cases, INT J GYN P, 19(3), 2000, pp. 225-230
Prognostic value of DNA cytometry in 281 premenopausal patients with lymphnode negative breast carcinoma randomized in a control trial - Multivariate analysis with Ki-67 index, mitotic count, and microvessel density
Authors: Mandard, AM Denoux, Y Herlin, P Duigou, F van de Vijver, MJ Clahsen, PC van den Broek, L Sahmoud, TM Henry-Amar, M van de Velde, CJH
Citation: Am. Mandard et al., Prognostic value of DNA cytometry in 281 premenopausal patients with lymphnode negative breast carcinoma randomized in a control trial - Multivariate analysis with Ki-67 index, mitotic count, and microvessel density, CANCER, 89(8), 2000, pp. 1748-1757
Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix
Authors: Kersemaekers, AMF van de Vijver, MJ Kenter, GG Fleuren, GJ
Citation: Amf. Kersemaekers et al., Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix, GENE CHROM, 26(4), 1999, pp. 346-354
Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer
Authors: Voogd, AC Peterse, JL Crommelin, MA Rutgers, EJT Botke, G Elkhuizen, PHM van Geel, AN Hoekstra, CJM van Pel, R van de Vijver, MJ Coebergh, JWW
Citation: Ac. Voogd et al., Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer, EUR J CANC, 35(13), 1999, pp. 1828-1837
The utility of mitotic index, oestrogen receptor and Ki-67 measurements inthe creation of novel prognostic indices for node-negative breast cancer
Authors: Clahsen, PC van de Velde, CJH Duval, C Pallud, C Mandard, AM Delobelle-Deroide, A van den Broek, L van de Vijver, MJ
Citation: Pc. Clahsen et al., The utility of mitotic index, oestrogen receptor and Ki-67 measurements inthe creation of novel prognostic indices for node-negative breast cancer, EUR J SUR O, 25(4), 1999, pp. 356-363
Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression
Authors: Elkhuizen, PHM Voogd, AC van den Broek, LCJM Tan, ITC van Houwelingen, HC Leer, JWH van de Vijver, MJ
Citation: Phm. Elkhuizen et al., Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression, INT J RAD O, 45(1), 1999, pp. 73-83
Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996)
Authors: Snijders-Keilholz, A Hellebrekers, BWJ Zwinderman, AH van de Vijver, MJ Trimbos, JB
Citation: A. Snijders-keilholz et al., Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996), RADIOTH ONC, 51(2), 1999, pp. 161-167
Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type
Authors: Vos, CBJ ter Haar, NT Rosenberg, C Peterse, JL Cleton-Jansen, AM Cornelisse, CJ van de Vijver, MJ
Citation: Cbj. Vos et al., Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type, BR J CANC, 81(8), 1999, pp. 1410-1418
Risultati: 1-19 |